Sacituzumab govitecan (SG) in patients (pts) with relapsed/refractory (R/R) advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II TROPiCS-03 basket trial Meeting Abstract


Authors: Michel, L.; Jimeno, A.; Sukari, A.; Beck, T.; Chiu, J. W. Y.; Ahern, E. S.; Hilton, J.; Hollebecque, A.; Zanetta, S.; Patel, J.; Mekan, S.; Wu, T.; Dumbrava, E. E.
Abstract Title: Sacituzumab govitecan (SG) in patients (pts) with relapsed/refractory (R/R) advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II TROPiCS-03 basket trial
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S558
Language: English
ACCESSION: WOS:001087480201195
DOI: 10.1016/j.annonc.2023.09.2005
PROVIDER: wos
Notes: Meeting Abstract: 859MO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Loren Michel
    61 Michel